Shanghai Haoyuan Chemexpress Future Growth
Future criteria checks 5/6
Shanghai Haoyuan Chemexpress is forecast to grow earnings and revenue by 38.3% and 23.6% per annum respectively. EPS is expected to grow by 38.8% per annum. Return on equity is forecast to be 8.5% in 3 years.
Key information
38.3%
Earnings growth rate
38.8%
EPS growth rate
Life Sciences earnings growth | 29.3% |
Revenue growth rate | 23.6% |
Future return on equity | 8.5% |
Analyst coverage | Low |
Last updated | 25 Apr 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,776 | 315 | N/A | 50 | 1 |
12/31/2025 | 3,156 | 226 | N/A | 34 | 3 |
12/31/2024 | 2,449 | 157 | N/A | -12 | 3 |
3/31/2024 | 1,967 | 98 | -169 | 113 | N/A |
12/31/2023 | 1,880 | 127 | -323 | -64 | N/A |
9/30/2023 | 1,764 | 154 | -610 | -286 | N/A |
6/30/2023 | 1,618 | 172 | -733 | -317 | N/A |
3/31/2023 | 1,476 | 178 | -808 | -384 | N/A |
12/31/2022 | 1,358 | 194 | -822 | -240 | N/A |
9/30/2022 | 1,243 | 205 | -787 | -111 | N/A |
6/30/2022 | 1,135 | 212 | -647 | -71 | N/A |
3/31/2022 | 1,044 | 199 | -515 | 2 | N/A |
12/31/2021 | 969 | 191 | -230 | 58 | N/A |
9/30/2021 | 918 | 202 | -2 | 114 | N/A |
6/30/2021 | 841 | 178 | 25 | 120 | N/A |
3/31/2021 | 736 | 160 | 81 | 165 | N/A |
12/31/2020 | 635 | 128 | 46 | 117 | N/A |
12/31/2019 | 409 | 73 | 37 | 58 | N/A |
12/31/2018 | 300 | 18 | -7 | 28 | N/A |
6/30/2017 | 150 | 31 | N/A | -26 | N/A |
3/31/2017 | 134 | 24 | N/A | -19 | N/A |
12/31/2016 | 117 | 18 | N/A | -12 | N/A |
9/30/2016 | 116 | 18 | N/A | 7 | N/A |
6/30/2016 | 96 | 11 | N/A | 17 | N/A |
3/31/2016 | 94 | 10 | N/A | 10 | N/A |
12/31/2015 | 92 | 9 | N/A | 2 | N/A |
12/31/2014 | 67 | 3 | N/A | -4 | N/A |
12/31/2013 | 59 | 2 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688131's forecast earnings growth (38.3% per year) is above the savings rate (2.9%).
Earnings vs Market: 688131's earnings (38.3% per year) are forecast to grow faster than the CN market (24.3% per year).
High Growth Earnings: 688131's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688131's revenue (23.6% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 688131's revenue (23.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688131's Return on Equity is forecast to be low in 3 years time (8.5%).